Helen Do-Gai Xue - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Helen Do-Gai Xue

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cancer Biology & Medicine|December 16, 2025

Harnessing the STING pathway for HCC treatmentCarmen Chak-Lui Wong, Cerise Yuen-Ki Chan, Helen Do-Gai Xue, et al.

JCI Insight|October 10, 2024

Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancerPo Yee Wong, Cerise Yuen Ki Chan, Helen Do Gai Xue, et al.

Journal of Hepatology|December 1, 2022

Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responsesVincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cancer Biology & Medicine|December 16, 2025

Harnessing the STING pathway for HCC treatmentCarmen Chak-Lui Wong, Cerise Yuen-Ki Chan, Helen Do-Gai Xue, et al.

JCI Insight|October 10, 2024

Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancerPo Yee Wong, Cerise Yuen Ki Chan, Helen Do Gai Xue, et al.

Journal of Hepatology|December 1, 2022

Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responsesVincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.

Pageof 1